These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Huang Y; Zhang Q; Wang JR; Lin KL; Mei X Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301 [TBL] [Abstract][Full Text] [Related]
8. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability. Laitinen R; Löbmann K; Grohganz H; Strachan C; Rades T Mol Pharm; 2014 Jul; 11(7):2381-9. PubMed ID: 24852326 [TBL] [Abstract][Full Text] [Related]
9. The use of molecular descriptors in the development of co-amorphous formulations. Meng-Lund H; Kasten G; Jensen KT; Poso A; Pantsar T; Rades T; Rantanen J; Grohganz H Eur J Pharm Sci; 2018 Jul; 119():31-38. PubMed ID: 29649569 [TBL] [Abstract][Full Text] [Related]
10. Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol. Pešić N; Dapčević A; Ivković B; Kachrimanis K; Mitrić M; Ibrić S; Medarević D Int J Pharm; 2021 Oct; 608():121033. PubMed ID: 34419592 [TBL] [Abstract][Full Text] [Related]
11. Comparison of co-former performance in co-amorphous formulations: Single amino acids, amino acid physical mixtures, amino acid salts and dipeptides as co-formers. Wu W; Grohganz H; Rades T; Löbmann K Eur J Pharm Sci; 2021 Jan; 156():105582. PubMed ID: 33039568 [TBL] [Abstract][Full Text] [Related]
12. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization. Ruponen M; Visti M; Ojarinta R; Laitinen R Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814 [TBL] [Abstract][Full Text] [Related]
14. Reducing mechanical activation-induced amorphisation of salbutamol sulphate by co-processing with selected carboxylic acids. Curtin V; Amharar Y; Gallagher KH; Corcoran S; Tajber L; Corrigan OI; Healy AM Int J Pharm; 2013 Nov; 456(2):508-16. PubMed ID: 23994365 [TBL] [Abstract][Full Text] [Related]
15. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives. Balani PN; Ng WK; Tan RB; Chan SY J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526 [TBL] [Abstract][Full Text] [Related]